Cargando…
Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704810/ https://www.ncbi.nlm.nih.gov/pubmed/35649533 http://dx.doi.org/10.1097/RHU.0000000000001857 |
| _version_ | 1784840137195126784 |
|---|---|
| author | Deodhar, Atul Chakravarty, Soumya D. Shiff, Natalie J. Lo, Kim Hung Xu, Stephen Hsia, Elizabeth C. Danve, Abhijeet Reveille, John D. |
| author_facet | Deodhar, Atul Chakravarty, Soumya D. Shiff, Natalie J. Lo, Kim Hung Xu, Stephen Hsia, Elizabeth C. Danve, Abhijeet Reveille, John D. |
| author_sort | Deodhar, Atul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9704810 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97048102022-12-13 Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study Deodhar, Atul Chakravarty, Soumya D. Shiff, Natalie J. Lo, Kim Hung Xu, Stephen Hsia, Elizabeth C. Danve, Abhijeet Reveille, John D. J Clin Rheumatol Concise Reports Lippincott Williams & Wilkins 2022-12 2022-06-02 /pmc/articles/PMC9704810/ /pubmed/35649533 http://dx.doi.org/10.1097/RHU.0000000000001857 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Concise Reports Deodhar, Atul Chakravarty, Soumya D. Shiff, Natalie J. Lo, Kim Hung Xu, Stephen Hsia, Elizabeth C. Danve, Abhijeet Reveille, John D. Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study |
| title | Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study |
| title_full | Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study |
| title_fullStr | Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study |
| title_full_unstemmed | Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study |
| title_short | Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study |
| title_sort | efficacy and safety of intravenous golimumab in patients with ankylosing spondylitis and complete spinal ankylosis: results through week 52 of the go-alive study |
| topic | Concise Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704810/ https://www.ncbi.nlm.nih.gov/pubmed/35649533 http://dx.doi.org/10.1097/RHU.0000000000001857 |
| work_keys_str_mv | AT deodharatul efficacyandsafetyofintravenousgolimumabinpatientswithankylosingspondylitisandcompletespinalankylosisresultsthroughweek52ofthegoalivestudy AT chakravartysoumyad efficacyandsafetyofintravenousgolimumabinpatientswithankylosingspondylitisandcompletespinalankylosisresultsthroughweek52ofthegoalivestudy AT shiffnataliej efficacyandsafetyofintravenousgolimumabinpatientswithankylosingspondylitisandcompletespinalankylosisresultsthroughweek52ofthegoalivestudy AT lokimhung efficacyandsafetyofintravenousgolimumabinpatientswithankylosingspondylitisandcompletespinalankylosisresultsthroughweek52ofthegoalivestudy AT xustephen efficacyandsafetyofintravenousgolimumabinpatientswithankylosingspondylitisandcompletespinalankylosisresultsthroughweek52ofthegoalivestudy AT hsiaelizabethc efficacyandsafetyofintravenousgolimumabinpatientswithankylosingspondylitisandcompletespinalankylosisresultsthroughweek52ofthegoalivestudy AT danveabhijeet efficacyandsafetyofintravenousgolimumabinpatientswithankylosingspondylitisandcompletespinalankylosisresultsthroughweek52ofthegoalivestudy AT reveillejohnd efficacyandsafetyofintravenousgolimumabinpatientswithankylosingspondylitisandcompletespinalankylosisresultsthroughweek52ofthegoalivestudy |